NEW YORK, Aug. 2, 2017 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Envision Healthcare Corporation ("Envision" or the "Company") (NYSE: EVHC). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.
The investigation concerns whether Envision and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here to join a class action]
On July 24, 2017, The New York Times reported that physicians associated with Envision's subsidiary EmCare Holdings Inc. were disproportionately likely to engage in "surprise billing," in which patients who go to in-network hospitals are treated by out-of-network doctors and subsequently billed at higher rates.
On this news, Envision's share price fell $2.33, or 3.72%, to close at $60.28 on July 24, 2017.
The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com
CONTACT:
Robert S. Willoughby
Pomerantz LLP
rswilloughby@pomlaw.com
